Effects of heme oxygenase-1 on innate and adaptive immune responses promoting pregnancy success and allograft tolerance by Anne Schumacher & Ana C. Zenclussen
REVIEW ARTICLE
published: 06 January 2015
doi: 10.3389/fphar.2014.00288
Effects of heme oxygenase-1 on innate and adaptive
immune responses promoting pregnancy success and
allograft tolerance
Anne Schumacher* and Ana C. Zenclussen
Department of Experimental Obstetrics and Gynecology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany
Edited by:
Ronald James Wong, Stanford
University School of Medicine, USA
Reviewed by:
Ryan Sol Funk, University of Kansas
Medical Center, USA
Hui Zhao, Stanford University, USA
*Correspondence:
Anne Schumacher, Department of
Experimental Obstetrics and
Gynecology, Medical Faculty,
Otto-von-Guericke University,
Gerhart-Hauptmann Straße 35,
39108 Magdeburg, Germany
e-mail: anne.schumacher@
med.ovgu.de
The heme-degrading enzyme heme oxygenase-1 (HO-1) has cytoprotective, antioxidant,
and anti-inﬂammatory properties. Moreover, HO-1 is reportedly involved in suppressing
destructive immune responses associated with inﬂammation, autoimmune diseases, and
allograft rejection. During pregnancy, maternal tolerance to foreign fetal antigens is a
prerequisite for successful embryo implantation and fetal development. Here, HO-1 has
been implicated in counteracting the overwhelming inﬂammatory immune responses
towards fetal allo-antigens, thereby contributing to fetal acceptance. Accordingly, HO-1
ablation negatively impacts the critical steps of pregnancy such as fertilization, implantation,
placentation, and fetal growth. In the present review, we summarize recent data on
the immune modulatory capacity of HO-1 towards allo-antigens expressed by the semi-
allogeneic fetus and organ allografts. In this regard, HO-1 has been shown to promote
alloantigen tolerance by blocking dendritic cell maturation resulting in reduced T cell
responses and increased numbers of regulatory T cells. Moreover, HO-1 is suggested
to shift the uterine cytokine milieu towards a protectiveTh2 proﬁle and protects fetal tissue
from apoptosis by upregulating anti-apoptotic molecules. Thus, HO-1 is not only a pivotal
regulator of the initial steps of pregnancy; but also, an important player in supporting the
maternal immune system in tolerating the fetus.
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INTRODUCTION
Heme oxygenase-1 (HO-1) has been widely described as an
enzyme with anti-inﬂammatory, antioxidant, and cytoprotec-
tive functions. Moreover, due to its ability to modulate immune
responses HO-1 has become an interesting target in several
clinical specialties including infectious diseases, immunology
(autoimmune diseases), oncology, transplantation, and obstet-
rics (fetal tolerance). HO-1 catalyzes the degradation of heme into
biliverdin, carbon monoxide (CO) and free iron, and there is evi-
dence that HO-1mediates its functions through these byproducts.
In response to inﬂammatory stimuli and oxidative stress HO-1 is
induced inmost cell types (Chauveau et al., 2005) where its expres-
sion activates or suppresses cell-intrinsic pathways. Hence, HO-1
is considered as one of the key regulators in the immunological
network. Here, we focus this review on the immune regulat-
ing properties of HO-1 towards allo-antigens presented by the
semi-allogeneic fetus or organ allografts on a cell-speciﬁc basis.
Under normal circumstances, recognition of foreign antigens
by allo-reactive T cells causes inﬂammatory processes that result in
the destruction of foreign antigens. During pregnancy, it is known
that some degree of inﬂammation is required to ensure successful
implantation of the blastocyst into the maternal endometrium.
However, pregnancy complications may develop if inﬂammation
becomes too excessive and is not counterbalanced by speciﬁc
tolerance against paternal antigens. An adequate regulation of
inﬂammation is thus a prerequisite for normal fetal development,
and we believe that HO-1 is crucially involved in this process.
In normal pregnancies, two HO isoforms, HO-1 and HO-2, are
present in human, rat and mouse placenta (Kreiser et al., 2003;
McLaughlin et al., 2003; Watanabe et al., 2004). HO-1 and HO-2
are differentially expressed and localized in the human placenta
(McLean et al., 2000; Yoshiki et al., 2000). Extensive work from
our group revealed that HO-1 controls critical phases through-
out pregnancy including ovulation, fertilization, placentation, and
fetal growth (Zenclussen et al., 2011, 2012; Linzke et al., 2014). The
role of HO-1 in pregnancy was also explored by other research
groups (Ahmed et al., 2000; Denschlag et al., 2004; Zhao et al.,
2008,2009). Absence of HO-1 expression and/or its activity is asso-
ciated with pregnancy complications in humans (Zenclussen et al.,
2003; Denschlag et al., 2004) and mice (Zenclussen et al., 2011).
Pharmacologic or gene therapy-mediatedHO-1upregulation pro-
tects the fetus from rejection (Sollwedel et al., 2005; Zenclussen
et al., 2006) revealing the therapeutic potential of HO-1 in the
treatment of pregnancy disorders.
In contrary to the physiologic condition of pregnancy, where
the maternal immune system is naturally challenged by fetal
allo-antigens, allotransplantation can be seen as an artiﬁcial
situation where the immune system of the recipient must tol-
erate the foreign antigens expressed by the graft against its
nature to accept it. However, it can be assumed that sim-
ilar mechanisms contribute to allo-tolerance in both condi-
tions and the knowledge of basic mechanisms by which the
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fetus guarantees its own survival may help to improve allo-
graft acceptance. In agreement with observations made for
pregnancy, HO-1 augmentation before or after allotransplanta-
tion is associated with increased allograft survival (Soares et al.,
1998; DeBruyne et al., 2000; Chen et al., 2010; Evans et al.,
2012). Thus, modulating the HO-1 system may be a promis-
ing tool to prevent acute and chronic rejections of allotrans-
plants.
EFFECTS OF HO-1 ON MONOCYTES AND MACROPHAGES
Numbers, subtypes, and functions of monocytes andmacrophages
change during normal pregnancy. Both immune cell popula-
tions favor blastocyst implantation and placentation by promoting
trophoblast invasion, spiral artery remodeling, and angiogenesis
[recently reviewed in (Faas et al., 2014)]. Through its metabolite
CO, HO-1 provokes differentiation of progenitors into functional
macrophages. Hence, ablation of HO-1 has been shown to prevent
macrophage differentiation and expression of its markers (Wegiel
et al., 2014). Accordingly, a lack of HO-1 or its byproducts may
impair implantation and placentation by affecting macrophage
generation and activity.
Interestingly, HO-1 may also alter the course of autoim-
mune diseases and infections in pregnancy via modulation of
myeloid-derived immune cell populations including monocytes
and macrophages. Multiple sclerosis (MS), a Th1-dominated
autoimmune disease, signiﬁcantly improves during the third
trimester of pregnancy and this is thought to be due to
pregnancy-speciﬁc alterations of immune responses. In a well-
established mouse model for MS, the experimental autoimmune
encephalomyelitis (EAE), the authors observed that animals
having a myeloid-speciﬁc HO-1 deﬁciency showed persistent
activation of antigen-presenting cells (APCs), enhanced Th17
inﬁltration, and increased myelin-speciﬁc T cell reactivity result-
ing in a higher disease activity (Tzima et al., 2009). Moreover,
Chora et al. (2007) nicely demonstrated that HO-1 and CO
reduced disease activity in EAE mice. Although highly specu-
lative, it can be assumed that HO-1 induction in pregnancy is
involved in the attenuation of MS symptoms during this time.
However, at present there is no direct proof for this beneﬁcial
effect.
Bacterial infections occurring during pregnancy are often
associated with spontaneous abortions or preterm births.
Macrophages are directly activated by microbial products and
are involved in the ﬁrst line of defense against bacterial inva-
sion and colonization. Lipopolysaccharide (LPS), a component
of the outer membrane of gram-negative bacteria, has been
shown to induce HO-1 upregulation in rodent macrophages
(Immenschuh et al., 1999), followed by a decreased expres-
sion of several pro-inﬂammatory genes (Otterbein et al., 2000).
Additionally, gram-negative bacteria, such as Helicobacter pylori,
induce polarization of macrophages to a more regulatory phe-
notype, resulting in a dampening of anti-bacterial immune
responses (Gobert et al., 2014). Moreover, cell speciﬁc HO-
1 inhibition in rodent macrophages was associated with a
reduced expression of IFN-β after infection with the gram-
positive bacteria Listeria monocytogenes. Because Listeria infec-
tion depends on IFN-β production, HO-1-deﬁcient animals
showed enhanced bacterial clearance and survival, while con-
trol mice succumbed to infection (Tzima et al., 2009). On the
other hand, Tachibana et al. (2011) showed that Listeria infec-
tions decrease HO-1 expression and induce placental cell death.
This is in agreement with our observations that mice infected
with Tritrichomonas foetus lost their concepti and displayed a
lower HO-1 expression in the uterus (Woudwyk et al., 2012).
These ﬁndings suggest that regulation of HO-1 levels by bacte-
ria favor bacterial persistence and, thereby facilitate embryonic
death.
In organ transplantation, the effect of HO-1 onmacrophages or
its expression by these cells is proposed to favor allograft tolerance.
Pre-treatment of pancreatic allografts prior to transplantation
with cobalt protoporphyrin (CoPP), a HO-1 inducer, markedly
increased HO-1 expression in donor macrophages. This was asso-
ciated with a signiﬁcant decrease in inﬂammatory cytokines and
an increase in anti-inﬂammatory cytokines to result in adequate
graft function and survival (Becker et al., 2007). In agreement,
pre-treatment of recipients or islet allografts with bilirubin, a
reduction product of biliverdin, before transplantation improved
graft survival in recipient mice. Moreover, donor treatment only
upregulated HO-1 mRNA expression and reduced the num-
ber of macrophages that inﬁltrate islet grafts in recipient mice
(Wang et al., 2006).
EFFECTS OF HO-1 ON GRANULOCYTES
The effect of HO-1 on granulocytes in pregnancy and in allotrans-
plantation has not been well studied. However, studies performed
in rodent models of inﬂammation showed that HO-1 and its
metabolites CO and biliverdin are able to reduce leukocyte rolling,
adhesion, and neutrophil inﬁltration as well as migration of
eosinophils to inﬂammatory sites (Freitas et al., 2006; Xia et al.,
2007; Lin et al., 2010; Chiang et al., 2013; Zhang et al., 2013).
In a human study, it was reported that treatment of partially
puriﬁed basophils with hemin, a HO substrate analog, signif-
icantly induced biliverdin production in these cells, indicating
that they do express HO. Additionally, hemin and exogenous
CO seem to impair basophil activation (Vannacci et al., 2003).
Interestingly, one study showed that activated regulatory T cells
(Treg) initiate HO-1 expression in neutrophils rendering them
to a suppressive phenotype (Lewkowicz et al., 2013). As Treg
are major players in the establishment and maintenance of allo-
tolerance, HO-1 induction in neutrophils may represent one
mechanism by which Treg regulate innate immune responses
towards allo-antigens.
EFFECTS OF HO-1 ON MAST CELLS
Mast cells (MCs) are key regulators of allergic diseases. After
activation, MCs release pre-formed and newly synthesized medi-
ators to induce inﬂammatory immune responses. Several studies
have suggested a protective role of HO-1 and its metabolites in
allergic inﬂammation partially mediated through MCs. Induc-
tion of HO-1 expression in MCs suppressed their degranulation
and production of inﬂammatory cytokines (Takamiya et al., 2002;
Yasui et al., 2007; Pae et al., 2008; Matsushima et al., 2009). Fur-
thermore, HO-1-expressing murine MCs restrained dendritic cell
(DC) maturation in vitro followed by a decreased capacity of
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the DCs to provoke proliferation of spleen mononuclear cells
(Ma et al., 2014).
Recently, we uncovered a critical role of MCs in pregnancy
success. We found that uterine MCs (uMCs) display a unique
phenotype and increase in number when a female becomes
receptive (Woidacki et al., 2013). Additionally, we conﬁrmed an
increase in HO-1 levels at the same time (Zenclussen et al., 2014).
Hence, it is conceivable that HO-1 is involved in uterine hom-
ing of MCs as well as in their local regulation. However, a direct
impact of HO-1 on MC migration and functionality needs to be
conﬁrmed. After pregnancy occurs, uMCs rapidly expand and
contribute to trophoblast survival, placentation, and fetal growth
(Woidacki et al., 2013) – processes inwhichHO-1playsmajor roles
(Zenclussen et al., 2006, 2011, 2012). It is, however, to remark that
an exaggerated augmentation of MC numbers or their activation
can be associated with negative pregnancy outcomes [reviewed
in (Woidacki et al., 2014)]. Further studies are needed to analyze
whether there is a direct association between HO-1 and MCs in
pregnancy.
The role of MCs in allograft rejection or tolerance is still not
deﬁned. There is evidence that inﬂammation resulting in allo-
graft rejection is suppressed by a reciprocal relationship between
MCs and Treg.While MCs contribute to Treg migration and func-
tion in the graft, Treg were shown to mitigate MC degranulation.
However, in the case of allergy, intragraft or systemic MC degran-
ulation may impair Treg homing and suppression and may result
in a breakdown of allograft tolerance (de Vries et al., 2009). The
interaction between MCs and Treg in allograft tolerance is further
underscored by a study of Lu et al. (2006). The authors showed
that activated Treg produce high levels of IL-9, thereby recruiting
and activating MCs in tolerant allografts where MCs can medi-
ate regional immune suppression (Lu et al., 2006). To what extent
HO-1 can regulate MC function and thereby contribute towards
MC-mediated allograft acceptance is not fully understood and
requires further investigations.
EFFECTS OF HO-1 ON NATURAL KILLER CELLS
Natural killer (NK) cells are the cytotoxic lymphocytes of the
innate immune system that mainly respond to virally infected
cells and tumor cells. During pregnancy, a unique subtype of NK
cells, the so-called uterine NK (uNK) cells, represent the major
cell fraction in the uterus. uNK cells express a speciﬁc receptor
repertoire that differs from that of peripheral NK cells. However,
the origin of uNK cells is still not deﬁned. They may be con-
verted from peripheral NK cells that are recruited to the uterus or
may expand via in situ proliferation (Inoue et al., 1996; Borzy-
chowski et al., 2003; van den Heuvel et al., 2005). In contrast
to their undeﬁned origin, there is a general consensus that they
have an indispensable role for appropriate spiral artery remodel-
ing that guarantees sufﬁcient fetal nutrition (Hatta et al., 2011).
We recently showed that HO-1 expression is important for the
presence of uNKs and their expansion during pregnancy. We
found that HO-1-deﬁcient implantation sites have low uNK cell
numbers and a decreased expression of uNK-related angiogenic
factors. This phenotype was associated with shallow spiral artery
formation leading to intrauterine growth restriction (IUGR) and
gestational hypertension. Interestingly, we were able to restore the
phenotype by application of low dose of CO during early to mid-
gestation. CO treatment provoked an in situ proliferation of uNK
cells, normalizing their numbers and further modulating angio-
genic parameters that ﬁnally favor vascular remodeling and the
prevention of hypertension (Linzke et al., 2014). Our results are
in agreement with a study by Zhao et al. (2011) who showed that
a partial HO-1 deﬁciency led to insufﬁcient spiral artery remod-
eling and alterations of uNK differentiation and maturation. The
authors further revealed that maternal HO-1 levels, but not fetal
HO-1 levels, are important for a successful formation of the feto-
maternal interface. These ﬁndings suggest a major inﬂuence of
HO-1 on uNK cells during normal pregnancy (Zhao et al., 2011).
Besides its pregnancy-favoring effect on uNK cells, HO-1may also
regulate NK cell function in allotransplantations, supporting allo-
graft acceptance. It is well accepted that NK cells can promote
rejection of allogeneic hematopoietic stem cells (Cudkowicz and
Rossi, 1972). Furthermore, NK cells may also initiate solid organ
transplant rejection by activating detrimental adaptive immune
responses. In this regard, NK cells have been shown to eliminate
immature DCs while sparing mature DCs, a behavior that pro-
motes increased T cell activation (Degli-Esposti and Smyth, 2005).
Moreover, NK cells can directly interact with T cells and induce
their differentiation into Th1 cells (Martin-Fontecha et al., 2004).
By killing Treg, NK cells further drive T cell-dependent allograft
rejection (Roy et al., 2008). Applicationof heme into rats preceding
cardiac allotransplantation augmented HO-1 levels followed by a
reduction of peripheral NK cell numbers and prolonged allograft
survival (Shen et al., 2011). However, data conﬁrming a protective
effect of HO-1 on NK cell-mediated allograft rejection are still
scarce and further studies are still needed to clarify this point.
EFFECTS OF HO-1 ON DENDRITIC CELLS
Dendritric cells can be seen as intermediates between the innate
and adaptive immune systems and have a major impact on the
fate of the semi-allogeneic fetus and the allograft. By present-
ing allo-antigens, mature DCs can induce the activation and
clonal expansion of allo-reactive T cells, thereby fostering the
rejection process. However, immature DCs, secreting mainly
anti-inﬂammatory cytokines, have been reported to suppress allo-
responses and may therefore play a rather favorable role in both
pregnancy and transplantation.
In terms of an effect mediated by HO-1, DCs are one of the
best-studied immune cell populations. Several studies indicate
that HO-1 affects both phenotype and function of DCs. Sponta-
neous HO-1 expression could be conﬁrmed in immature human
and rat DCs, while maturation resulted in a drastic decline of HO-
1. In line, induction of HO-1 by CoPP-inhibited LPS-induced
DC maturation, secretion of pro-inﬂammatory cytokines, and
induction of reactive oxygen species (ROS). Additionally, such
HO-1-producing DCs retained their ability to produce IL-10 and
had a lower T cell stimulatory capacity. Accordingly, inhibition
of HO activity led to increased ROS levels, a mature phenotype,
impaired phagocytic and endocytic functions, and increased T
cell stimulatory capacity (Al-Huseini et al., 2014). These ﬁndings
support the idea that HO-1 directs DCs towards a tolerogenic pro-
ﬁle. Normal pregnancy is characterized by uterine DCs (uDCs)
presenting an immature phenotype and mainly producing IL-10
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(Kammerer et al., 2003; Blois et al., 2004). In contrast, abortions
in mice are associated with an increased number of mature, IL-
12-producing DCs (Blois et al., 2005). Our working group showed
in collaboration with Dr. Tadokoro that, in vivo, DCs accumulate
even before pregnancy during the estrous cycle, suggesting a role
for these cells in embryo implantation (Zenclussen et al., 2013).
Indeed, Plaks et al. (2008) revealed that a depletion of uDCs had
detrimental effects on the decidualization process by interfering
with the implantation of the embryos, which ﬁnally lead to their
demise. Furthermore,HO-1 supports pregnancy success by retain-
ing DCs in an immature state, thereby attenuating allo-reactive T
cell responses andpromoting the expansionof pregnancy-favoring
Treg (Schumacher et al., 2012).
Similar to fetal rejection, failure of allograft acceptance is often
caused by direct and indirect antigen-presenting pathways where
DCs initiate anti-alloantigen-speciﬁc adaptive immune responses.
In amurinemodel for transplant arteriosclerosis, adoptive transfer
of HO-1-deﬁcient DCs before allograft transplantation or inhibi-
tion of endogenous HO-1 in allograft recipients was associated
with pronounced intragraft T cell inﬁltration and increased IgG
deposition, resulting in elevated graft immunogenicity (Cheng
et al., 2010). On the other hand, HO-1 induction in organ donors
prior to organ transplantation may reduce activation of donor
DCs and intra-allograft T cell inﬁltration while simultaneously
promoting Treg development (Kotsch et al., 2007; Sun et al., 2011).
These ﬁndings indicate that HO-1 expression has a major impact
on DCs, an immune cell population with the ability to induce or
suppress allo-responses.
EFFECTS OF HO-1 ON B CELLS
B cells are allocated to the adaptive arm of the immune system
and are best known for their capability to secrete antibodies.
However, B cells are also able to efﬁciently present antigens and
modulate the function of T cells and DCs by producing cytokines
(Porakishvili et al., 2001; Youinou et al., 2005). Hence, it can be
assumed that B cells are involved in essential immune regula-
tory processes promoting either fetal acceptance or rejection. We
reported that various B cell subsets differentially affect pregnancy
outcomes (Muzzio et al., 2013). In this regard, human B-1a B cells,
known to produce poly reactive natural antibodies were reported
to play a role in pre-eclampsia (Vannacci et al., 2003). In mice,
B-1a B cells direct naive T cells towards an inﬂammatory Th1 and
Th17 phenotype, and are therefore involved in cellular immune
responses associated with pregnancy complications (Muzzio et al.,
2014). In contrast, B cells contribute to fetal tolerance as well. It
has been shown that the production of a structural unique type of
antibodies, the so-called asymmetric antibodies, favor pregnancy
success (Margni et al., 1976). Furthermore, there is evidence that
IL-10-producing B cells with regulatory properties support fetal
survival (Jensen et al., 2013; Rolle et al., 2013). The role of B cells
in pregnancy has been recently reviewed (Fettke et al., 2014).
In the ﬁeld of transplantation, B cells account for acute and
chronic rejections (recently reviewed by (Nouel et al., 2014)). By
presenting allo-antigens toT cells and by producing donor-speciﬁc
antibodies, B cells initiate allograft rejection (Noorchashm et al.,
2006). Intra-allograft B cell inﬁltration has therefore been associ-
atedwithpoor graft survival (Hippen et al., 2005). On the contrary,
regulatory B cells (Bregs) have a rather favorable inﬂuence on
allograft survival. Two human studies showed that an increased
frequency of Bregs was found in tolerant renal transplanted
patients (Newell et al., 2010; Pallier et al., 2010).
An action of HO-1 on B cells during pregnancy and organ
transplantation is widely unexplored. HO-1 is expressed in nor-
mal and malignant human B cells after induction of oxidative
stress, whereby malignant B cells exhibit a greater HO-1 expres-
sion (Bancos et al., 2010). Kapturczak et al. (2004) performed
an elegant study, which compared the immune phenotype of
HO-1 deﬁcient with wild-type mice. Although the lack of HO-
1 was associated with splenomegaly, analysis of splenocytes
revealed no differences in the proportion of B cells. How-
ever, the authors found lower numbers of B220+ B cells in
lymph nodes and signiﬁcantly elevated serum IgM levels in
HO-1-deﬁcient animals (Kapturczak et al., 2004). In agreement,
addition of heme to primary B cell cultures skews plasma cell
differentiation toward the IgM isotype, decreasing IgG levels in
vitro (Watanabe-Matsui et al., 2011). From these data, it can
be assumed that in the presence of HO-1, destructive allo-
antibody responses are controlled. In addition, injection of a
recombinant adeno-associated viral vector (serotype 1) encoding
IL-10 (rAAV1-IL-10) in a rat model of aortic allograft trans-
plantation resulted in a signiﬁcant reduction of graft inﬁltration
with macrophages and B and T cells. The authors found that
the protective effects of IL-10 were mediated through HO-1.
This implies that HO-1 may regulate B cell inﬁltration into tis-
sues where allo-antigens provoke inﬂammatory responses (Chen
et al., 2005). This is a very interesting theory that needs further
exploration.
EFFECTS OF HO-1 ON T CELLS
T lymphocytes are key regulators of humoral- and cell-mediated
immune responses. T helper cells expressing CD4 and CD8-
expressing cytotoxic T cells are the two main T cell subpopula-
tions. Furthermore, although oversimpliﬁed, T cells are usually
subdivided into Th1, Th2, Th9, and Th17 cells according to
their cytokine secretion pattern. By secreting cytokines, T cells
deﬁne their local environment as either pro-inﬂammatory or
anti-inﬂammatory. Normal pregnancy is characterized by a pro-
inﬂammatory Th1 proﬁle at early and late pregnancy stages that is
critical for proper trophoblast invasion and later on for initiation
of labor. Atmid-gestation,mechanisms allowing the acceptance of
fetal allo-antigens provoke a more Th2-dominated proﬁle. Imbal-
ances in these cytokine proﬁles are thus often associated with
pregnancy complications (Hudic and Fatusic, 2009).
After organ transplantation allo-antigens trigger the activation
and proliferation of T cell responses. Consequently, CD8+ T cells
induce cell-mediated cytotoxicity, while CD4+ T cells promote B
cell maturation and differentiation into allo-antibody-producing
plasma cells. Additionally, T cells secrete soluble factors that acti-
vate and recruit immune cells to the site of the allograft and ﬁnally
provoke its rejection.
Modulation of T cell responses is suggested to be one of the
major mechanisms by which HO-1 contributes to fetal and allo-
graft survival. During normal pregnancy, HO-1 expression may
at least partially be responsible for the Th2 shift observed during
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FIGURE 1 | Hypothetical scenario of HO-1-mediated effects on innate and adaptive immune cell populations supporting fetal and allotransplant
tolerance.
mid-gestation. This is supported in our studies, which showed
that adenoviral-mediated upregulation of HO-1 in abortion-
prone animals increased the Th2/Th1 ratio and protected fetuses
from rejection (Zenclussen et al., 2006). Accordingly, induction
of HO-1 by CoPP in allotransplant recipients led to a reduc-
tion in the pro-inﬂammatory cytokine milieu (Ewing et al., 2007),
leading us to propose a similar protective mechanism during
allotransplantation.
Treg are central players in the regulation of fetal and allograft
tolerances. While an augmentation of Treg at the fetomaternal
interface and in the allograft is associated with pregnancy success
and a good prognosis of graft acceptance, the lack of Treg often
results in pregnancy complications and allograft rejection.
Several studies indicate that HO-1 and its byproducts
affect the development and function of human and murine
CD4+ and CD8+ Treg as well as the production of Treg-
related suppressive molecules (Pae et al., 2003; Choi et al., 2005;
El Andaloussi and Lesniak, 2007; Lee et al., 2007; Xia et al., 2007;
Brandsma et al., 2008; Mougiakakos et al., 2011; Sun et al., 2011;
Karimi et al., 2012). Andersen et al. (2009) propose that Treg
expressing HO-1 are able to inhibit cytokine release, prolifera-
tion, and cytotoxicity of other immune cells. However, this is
in contrast, to a study by Biburger et al. (2010) who reported
that HO-1 expression by human Treg inﬂuences their proliferative
behavior, but not their suppressive capacity. Moreover, Zelenay
et al. (2007) provided evidence that in HO-1-deﬁcient animals,
Treg development, maintenance, and function are independent
of HO activity. In these animals, the absence of HO-1 in APCs
seemed to abolish the suppressive activity of Treg (George et al.,
2008). After previously reporting that adoptive Treg transfer can
rescue fetuses from immunological rejection (Schumacher et al.,
2012), we investigated the inﬂuence of HO-1 on Treg-mediated
fetal protection. We proved that inhibition of HO-1 abrogated
the protective effects of the Treg transfer suggesting that HO-1 is
FIGURE 2 | Consequences of HO-1-deficiency for pregnancy outcome and allograft acceptance.
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involved in a Treg-mediated suppression during murine pregnan-
cies (Schumacher et al., 2012). Altogether these ﬁndings suggest
that HO-1 affects several important aspects in T cell biology,
including T cell proliferation, cytokine secretion, and the induc-
tion of T cells with regulatory properties. Hence, modulation
of T cell and in particular Treg responses through HO-1 repre-
sent a promising tool for the induction of fetal and allotransplant
tolerance.
EFFECTS OF HO-1 ON PROCESSES ENSURING TROPHOBLAST
SURVIVAL
Placental development is a well-deﬁned process of trophoblast
proliferation and apoptosis. Irregularitieswithin this process result
in abnormal placentation and may cause pre-eclampsia, where
an increased apoptotic rate of trophoblast cells was documented
(Allaire et al., 2000; Sharp et al., 2010). HO-1 seems to directly
inﬂuence trophoblast survival. By using a rat trophoblastic stem
cell line that is capable of differentiating into trophoblast giant
cells, we showed that HO-1 inhibition diminished cell viabil-
ity and ability to differentiate into giant cells (Zenclussen et al.,
2011). Thus, HO-1 regulates both the survival and maturation of
trophoblast cells. Moreover, we found that adenoviral-mediated
HO-1 induction in mice led to increased levels of the anti-
apoptotic molecule Bag-1 and reduced the number of apoptotic
cells in placental tissue (Zenclussen et al., 2006). In line,we recently
conﬁrmed that in partially deﬁcient HO-1 animals, LPS treatment
signiﬁcantly reduced Bag-1 levels in placental tissue. In the same
study, we found that human trophoblasts from spontaneous abor-
tion patients had lower basal levels of HO-1 when compared to
trophoblasts from normal pregnant women. The low HO-1 levels
in trophoblasts from spontaneous abortion patients were further
associated with a diminished Bag-1 expression (Kahlo et al., 2013).
In an in vivo setting, we proved that exposure of CO during
the implantation window and early placentation also reduced the
number of apoptotic cells in the murine placenta and increased
Bag-1 expression, implicating that the protective function of HO-
1might bemediated through its byproduct CO (El-Mousleh et al.,
2012). Ourwork is in agreementwithwork fromZhao et al. (2009)
who revealed that placentas from breedings of partially deﬁcient
HO-1 mice remained comparatively smaller and displayed lower
placental weights than those from wild-type breedings. Lower
HO-1 expression in heterozygous placentas was associated with
an increase in apoptosis. These ﬁndings suggest that HO-1 not
only modulates immune responses to ensure survival of fetal tis-
sue; but also, supports pregnancy success by directly inﬂuencing
trophoblast survival.
CONCLUSION
There is accumulating evidence that HO-1 and its byproducts
affect the development and function of a variety of immune
cells during pregnancy and allotransplantation (Figure 1). Detri-
mental immune responses towards the foreign allo-antigens are
modulated and/or suppressed allowing the survival of the fetus
in the hostile uterine environment and the acceptance of the
allograft by its recipient. However, HO-1 deﬁciency may result
in fetal and allograft rejection (Figure 2). HO-1-based thera-
pies may be promising strategies to circumvent both, fetal and
allotransplant rejections. These approaches may include pharma-
cologic or gene therapy-mediated induction of HO-1 as well as
the administration of CO. Treg known to be essential for fetal and
allotransplant tolerance may hereby represent a major target of
HO-1 modulation.
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